Similarly, GBM patients with high CD8+ T cell abundance and high CD69 gene expression (Figure 7B, group 4) showed better cumulative survival (>80 months), as compared to those patients with a low CD8+ T cells abundance and high CD69 gene expression (Figure 7B, group 3). The gene discussed is CD69; the disease is glioblastoma.